Post by Arise News (@arisenews)

9 June 2026

GSK agrees to acquire Nuvalent for $10.6bn, strengthening its position in cancer drug development and expanding its oncology pipeline.

Source: https://www.arise.tv/gsk-to-acquire-nuvalent-for-10-6bn-in-cancer-drug-push

0 likes · 0 comments · 0 shares